A miracle drug for atopic eczema

In July 2019, Swissmedic validated Dupixent, a recent treatment for atopic eczema, for the Swiss market. This biomedicine administered by injection could mark the end of the ordeal for the 40,000 people suffering from this severe form of eczema in Switzerland.